Equetro Approved for the Treatment of Bipolar Disorder

Shire Pharmaceuticals Group has announced that the US Food & Drug Administration (FDA) has approved Equetro, which is an extended-release form of carbamazepine capsules, for the treatment of patients with bipolar disorder. Equetro is indicated for the treatment of acute manic and mixed episodes associated with bipolar I disorder. Read More